| Date |
Title |
Rating |
| 2009-10-31 |
London Genetics enters an intensive partnering programme |
None |
| 2009-10-31 |
Performance-focused metrics supporting forward-looking decision making critical for drug companies |
None |
| 2009-10-31 |
New report on the global addiction pharmacotherapeutic market |
None |
| 2009-10-31 |
New study results of INTUNIV presented at a major psychiatric medical meeting |
None |
| 2009-10-31 |
Report on current perspectives in drug anti-counterfeiting strategies |
None |
| 2009-10-31 |
Exposure to mercury-based preservative in vaccines is minimal, says researchers |
2.7 |
| 2009-10-31 |
Requests to compound liquid Tamiflu have steadily increased over the past couple of weeks |
None |
| 2009-10-31 |
CeloNova BioSciences submits a request for approval of its new Embozene Microsphere |
1 |
| 2009-10-31 |
Replenish+ delays the progression of AIDS in HIV-infected patients not receiving ART |
None |
| 2009-10-31 |
Revised standards for four ingredients widely used in prescription and over-the-counter drugs announced |
None |
| 2009-10-31 |
Procter & Gamble's Vicks products containing vitamin C being marketed unlawfully, FDA warns |
None |
| 2009-10-31 |
FDA approves Covidien's Abbreviated New Drug Application for CII |
4 |
| 2009-10-31 |
Women may need smaller dose of H1N1 vaccine |
5 |
| 2009-10-31 |
FDA-approved drug PEG-ADA shows positive results in relieving major complication of priapism |
None |
| 2009-10-31 |
FDA approves an expanded indication for BYETTA injection |
None |
| 2009-10-31 |
Data from multiple clinical and preclinical studies evaluating Hematide announced |
None |
| 2009-10-30 |
China Medicine announces acquisition of Guangzhou LifeTech Pharmaceuticals |
None |
| 2009-10-30 |
Impax Laboratories initiates patent challenge for TRICOR |
None |
| 2009-10-30 |
Wyeth's strategies in the global pharmaceutical market |
None |
| 2009-10-30 |
VIA Pharmaceuticals to discuss its cardio-metabolic product portfolio at the Target 2009 conference |
None |
| 2009-10-30 |
Health officials stress the need for continued prevention efforts in view of H1N1 vaccine delay |
None |
| 2009-10-30 |
Trusted Process thought leaders at INC Research named winners at the 2009 Clinical Research Excellence Awards |
None |
| 2009-10-30 |
Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event |
None |
| 2009-10-30 |
Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots |
None |
| 2009-10-30 |
Report on the strategic assessment of GlaxoSmithKline |
None |
| 2009-10-30 |
36 individuals in Kentucky face federal prescription pill charges |
None |
| 2009-10-30 |
Mintel predicts increased sales of OTC drugs in upcoming months |
None |
| 2009-10-30 |
Clinical data on the validation set 'Alzheimer patients versus healthy controls' for AclarusDx presented |
None |
| 2009-10-30 |
ARYx Therapeutics to complete an out-licensing agreement for clinical development and commercialization of budiodarone |
None |
| 2009-10-30 |
Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting |
None |
| 2009-10-30 |
Studies demonstrate that investigational cancer vaccines show encouraging immune response rates |
5 |
| 2009-10-30 |
USANA’s Active Calcium Chewable supplement improves bone health in young girls |
None |
| 2009-10-30 |
Any cuts to the prescription drug program will affect senior citizens, says Network/Alliance |
None |
| 2009-10-30 |
The Netherlands Antilles Public Health Inspectorate issues importation approval for TNS' ImmuSANO and GlucoSANO |
None |
| 2009-10-30 |
Highly publicized vaccine products not only boost pharmaceutical companies, but also benefit others |
5 |
| 2009-10-30 |
Virtual Pharma Rep 360 Managed Care solution released |
None |
| 2009-10-30 |
Comparative study of chronic wound treatment completed |
None |
| 2009-10-30 |
FluGen's CHO-cell-based production system generates egg-free, 2009 H1N1 influenza vaccine virus |
None |
| 2009-10-30 |
All Canadians need to be immunized against H1N1: CPHA |
None |
| 2009-10-30 |
Researchers use BEZ235 drug to eliminate NSCL cancer |
None |
| 2009-10-30 |
Anabolic steroids may cause severe kidney dysfunction |
None |
| 2009-10-30 |
Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine |
None |
| 2009-10-30 |
New online education course on H1N1 vaccination now available |
None |
| 2009-10-30 |
Researchers show Simvastatin prevents Parkinson's disease from progressing further |
None |
| 2009-10-30 |
Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women |
None |
| 2009-10-30 |
Pharmaceutical companies accept Ecuador's decision to break drug patents |
None |
| 2009-10-30 |
U.S. won't donate H1N1 vaccine to developing countries until 'at-risk' Americans receive vaccine |
None |
| 2009-10-30 |
Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection |
None |
| 2009-10-29 |
Obama administration hits reset button in wake of flu vaccine shortage |
None |
| 2009-10-29 |
Roger Tung to receive 2009 Mass High Tech All Star award for his contributions to pharmaceutical industry |
None |
| 2009-10-29 |
Publix Supermarkets to sell HeartSavior and LipidShield Plus |
None |
| 2009-10-29 |
Tool to support the development of age-based dosing regimens for malaria drugs developed |
None |
| 2009-10-29 |
Bio-Pharmaceutical Summit 2009 to be held in China |
None |
| 2009-10-29 |
Challenges in the life sciences industry |
None |
| 2009-10-29 |
Analysis of orphan drug development and approval trends |
None |
| 2009-10-29 |
Winning placement on Managed Care formularies, the first step for product's increased market share |
None |
| 2009-10-29 |
Report on marketing the bio-pharmaceutical products released |
None |
| 2009-10-29 |
Analysis of the current and future anticonvulsant drug class market |
None |
| 2009-10-29 |
Ergoplex, an anti-inflammatory product, receives good response in direct mail test |
4 |
| 2009-10-29 |
Long-term effects of statin therapy could lead to transient or permanent cognitive impairment |
5 |
| 2009-10-29 |
Growth of the antidiabetics market to be driven by DPP-IV inhibitors and GLP-1 agonists |
None |
| 2009-10-29 |
Pipeline status of allergy drugs, new developments and disease specific projects |
None |
| 2009-10-29 |
New report on the current drug pipeline, latest news and developments |
None |
| 2009-10-29 |
Repros Therapeutics amends its existing license for Proellex |
None |
| 2009-10-29 |
AAHP updates about the sale of homeopathic medicines to prevent the flu |
None |
| 2009-10-29 |
Supportive data from a preclinical study of SCY-635 to be presented |
None |
| 2009-10-29 |
FDA issues a Complete Response Letter regarding NDA for Intermezzo |
None |
| 2009-10-29 |
Cempra Pharmaceuticals stages a presentation on CEM-101 |
None |
| 2009-10-29 |
Treatment of angina patients with ivabradine reduces risk of cardiovascular death |
None |
| 2009-10-29 |
Modern techniques can reduce current shortage of H1N1 vaccine in the U.S. |
5 |
| 2009-10-29 |
Dysport drug for treatment of cervical dystonia launched in the United States |
None |
| 2009-10-29 |
Steroid-induced osteoporosis can now be treated with Teriparatide |
None |
| 2009-10-29 |
AAHP confirms homeopathic medicines for prophylaxis of infectious diseases |
None |
| 2009-10-29 |
Iron-folic acid supplements during pregnancy can reduce offspring’s mortality rate |
4 |
| 2009-10-29 |
New microcapsules can deliver drugs at required target in the body |
None |
| 2009-10-29 |
Current drug pipeline report from Research and Markets |
None |
| 2009-10-29 |
No scientific proof that patients with Alzheimer's disease benefit from drugs containing the agent memantine |
None |
| 2009-10-29 |
TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs |
None |
| 2009-10-28 |
iMDsoft and Codonics launch an anesthesia solution with a syringe labeling system |
3 |
| 2009-10-28 |
Nevada case raises question of pharmacies' liability in drug abuse accidents |
None |
| 2009-10-28 |
CDC says U.S. H1N1 vaccine supplies on the rise; Senators question government's handling of H1N1 vaccination program |
None |
| 2009-10-28 |
Newspaper investigates dangerous mix of nursing homes and psychotropic drugs |
None |
| 2009-10-28 |
CDC: H1N1 vaccine supplies on the rise |
None |
| 2009-10-28 |
Can radical changes to structures and strategies of pharmaceutical R&D operations increase productivity? |
None |
| 2009-10-28 |
FDA approves the 100th antiretroviral drug in association with PEPFAR |
None |
| 2009-10-28 |
Enrollment for Phase 2 clinical study of NKTR-102 completed ahead of schedule |
None |
| 2009-10-28 |
73% increase in antiviral prescriptions in the past two weeks: SDI |
None |
| 2009-10-28 |
Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis |
None |
| 2009-10-28 |
Research and Markets offers a course on the important advances in internal medicine |
None |
| 2009-10-28 |
In-depth analysis of Phase II and III disease modifying drug candidates in rheumatoid arthritis pipeline |
None |
| 2009-10-28 |
Report on different approaches to reduce Phase II attrition |
None |
| 2009-10-28 |
NSF awards $3 million grant for establishing a Partnership in Research and Education in Materials |
None |
| 2009-10-28 |
Amgen to reduce price of Neulasta following Board's orders |
None |
| 2009-10-28 |
Study of ‘real-life’ experiences of patients undergoing 5-ASA treatment for ulcerative colitis |
None |
| 2009-10-28 |
Datamonitor's report on the global hormonal contraceptive market |
None |
| 2009-10-28 |
Treatment with TYSABRI reduces the rate of hospitalization in Crohn’s patients |
None |
| 2009-10-28 |
Report on the pipeline status of indigestion drugs |
None |
| 2009-10-28 |
Applications of pharmacogenomics in drug development |
None |
| 2009-10-28 |
New clinical uses for old hypertension drug leads to several patents |
None |
| 2009-10-28 |
Antidepressant market to decline: Datamonitor |
None |
| 2009-10-28 |
Folate-enriched prescription medical food lowers medical costs of patients with peripheral neuropathy |
None |
| 2009-10-28 |
Report on evolving market dynamics of antiretroviral drugs |
None |
| 2009-10-28 |
TOPROL-XL and metoprolol succinate are available for patients in all regions across the country: AstraZeneca |
None |
| 2009-10-28 |
Comprehensive report on Hepatitis C drug products |
None |
| 2009-10-28 |
Report on the U.S. pharmaceutical preparation manufacturing industry |
None |
| 2009-10-28 |
Shire receives European approval for FOSRENOL |
None |
| 2009-10-28 |
Precision Antibody to develop antibodies for NCI's Clinical Proteomic Technologies for Cancer |
None |
| 2009-10-28 |
Upsher-Smith Laboratories publishes data on Slo-Niacin and Lipitor combination study |
5 |
| 2009-10-28 |
Microbix and Hunan Biopharmaceutical to build $200-million influenza vaccine facility |
None |
| 2009-10-28 |
Pediatric and adolescent patients who receive antipsychotic medications experience weight gain |
5 |
| 2009-10-28 |
Recruitment of Phase II trial of TB-402 completed ahead of schedule |
None |
| 2009-10-28 |
Report on the Turner's syndrome drug pipeline |
None |
| 2009-10-28 |
POZEN announces Phase I study results of PA65020 |
None |
| 2009-10-28 |
Mirafit fbcx reduces human body absorption of consumed fat |
3.6 |
| 2009-10-28 |
Drug-cocktail approach offers hope in developing single agent to treat drug-resistant H1N1 swine flu |
None |
| 2009-10-28 |
NovaDel and Mist Acquisition enter into licensing agreement to manufacture and commercialize NitroMist |
None |
| 2009-10-28 |
King Pharmaceuticals receives exclusive rights to market and sell CYANOKIT |
None |
| 2009-10-28 |
Scientists explore genetic 'Prozac markers'; research may provide simple test for treating depression |
None |
| 2009-10-27 |
Medicines used for lowering blood cholesterol may be effective in the treatment of cancer |
None |
| 2009-10-27 |
H1N1 overwhelms hospitals; Sebelius addresses flu vaccine shortage |
None |
| 2009-10-27 |
China places third purchase order for H1N1 vaccine with Sinovac Biotech |
None |
| 2009-10-27 |
Report on the future market potential for monoclonal antibodies |
None |
| 2009-10-27 |
Astellas enters into agreement with Medivation to develop MDV3100 |
None |
| 2009-10-27 |
New systematic study for managing treatment-resistant bipolar depression |
None |
| 2009-10-27 |
PolyMedix completes second successful clinical study of PMX-60056 |
5 |
| 2009-10-27 |
Boston Medical Center deploys Fusionfx Immunization Management portal to manage H1N1 vaccination |
5 |
| 2009-10-27 |
Report on top 60 European generic pharmaceutical manufacturers |
3.8 |
| 2009-10-27 |
Report on immunotherapies and vaccines for nontraditional indications |
None |
| 2009-10-27 |
Study reveals that adding ezetimibe to atorvastatin aids in reducing cholesterol |
None |
| 2009-10-27 |
Analysis of recent trends in medicinal chemistry and its significance in drug discovery |
5 |
| 2009-10-27 |
CCPM coalition members urge Congress to fix or drop the current biogenerics provision |
None |
| 2009-10-27 |
Analysis of the ion channel modulator pipeline |
None |
| 2009-10-27 |
New anti-flu drugs to fight flu virus could become a reality |
3 |
| 2009-10-27 |
Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage |
None |
| 2009-10-27 |
USAID and USP join to combat substandard and counterfeit medicines |
None |
| 2009-10-27 |
HealthCore study shows Metanx tablets reduces health plan costs |
5 |
| 2009-10-27 |
LX211 may become the first approved oral treatment for modifying the course of uveitis |
None |
| 2009-10-27 |
New data on KAPIDEX for nighttime heartburn in adults with non-erosive GERD presented at the 2009 ACG |
None |
| 2009-10-27 |
FDA warns four companies to stop marketing illegal opioid pain relievers |
None |
| 2009-10-27 |
Shire reports results of Lialda and 5-ASA persistency analyses |
None |
| 2009-10-27 |
New market research report on techniques, technology and software used in life science data mining |
None |
| 2009-10-27 |
Study reveals LOAD therapy can eliminate bacterium in patients with gastritis and peptic ulcers |
None |
| 2009-10-27 |
Pregabalin reduces abdominal pain and improves sleep in women with adhesions |
None |
| 2009-10-27 |
Anti-Infective Drugs Advisory Committee to review aztreonam for inhalation solution |
None |
| 2009-10-27 |
New market research report on China pharmaceutical industry |
None |
| 2009-10-27 |
TNF-alpha inhibitors and interleukin inhibitors to drive psoriasis drug market |
None |
| 2009-10-27 |
Arzerra drug approved by FDA for treating chronic lymphocytic leukemia |
None |
| 2009-10-27 |
Oral contraceptives increase stroke risk but benefits still outweigh risks for most users |
None |
| 2009-10-27 |
FDA approves Berinert for adults and adolescents with HAE |
None |
| 2009-10-27 |
Natural, aspartame-free, multi-vitamins for children |
None |
| 2009-10-27 |
Inhibikase Therapeutics to illustrate the utility of IkT-001 and IkT-041 to treat multiple infectious diseases |
None |
| 2009-10-27 |
New data demonstrates CREON Delayed-Release Capsules improve fat absorption in adults with EPI |
None |
| 2009-10-27 |
Dartmouth explores glucorticoid side effects on bladder-cancer patients |
None |
| 2009-10-27 |
Champions Biotechnology expands collaboration to accelerate oncology drug development |
None |
| 2009-10-27 |
Innovative approach to build a new drug to treat a number of CNS diseases |
None |
| 2009-10-26 |
Swine flu 'emergency' declaration could mean expedited care |
None |
| 2009-10-26 |
ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans |
None |
| 2009-10-26 |
Dysport, a new wrinkle fighter, available now in the United States |
None |
| 2009-10-26 |
Cel Sci completes its production facility for Multikine Phase III clinical trial |
None |
| 2009-10-26 |
UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009 |
None |
| 2009-10-26 |
Anti-viral drug development programs progress successfully, reports NanoViricides |
None |
| 2009-10-26 |
Report: Multinational pharmaceutical companies looking to increase sales in India |
None |
| 2009-10-26 |
FDA grants five-year New Chemical Entity exclusivity to VYVANSE |
None |
| 2009-10-26 |
Dexmedetomidine can reduce pain when removing a tube from the airway of critically ill patients |
None |
| 2009-10-26 |
New findings demonstrating pharmacoeconomic benefits of Ceplene released |
None |
| 2009-10-26 |
Omega-3 fatty acid supplements do not improve levels of depression in heart disease patients |
None |
| 2009-10-26 |
Dextrose solution decreases postoperative nausea and vomiting |
None |
| 2009-10-24 |
ULURU presents clinical posters; highlights efficacy of Altrazeal dressing for wound care |
None |
| 2009-10-24 |
Lpath to present clinical results of iSONEP drug in wet-AMD patients |
None |
| 2009-10-24 |
FDA issues emergency use authorization for peramivir anti-viral drug |
None |
| 2009-10-24 |
CHMP grants positive opinion to extend the use of Angiox to patients undergoing PCI |
None |
| 2009-10-24 |
Report on the world outlook for prophylactic vaccines |
None |
| 2009-10-24 |
African American seniors less likely to be vaccinated against flu; fear and misinformation pose problems |
None |
| 2009-10-24 |
Pregnant women unsure about getting H1N1 flu shot, shows new survey |
5 |
| 2009-10-24 |
Potentia Pharmaceuticals and Alcon Research sign license and purchase option agreements |
None |
| 2009-10-24 |
Human clinical trials of TissuGlu to commence in Germany |
None |
| 2009-10-24 |
MPI Research to assist Kineta in autoimmune drug development program |
None |
| 2009-10-24 |
FDA issues emergency use authorization for intravenous antiviral drug peramivir in H1N1 patients |
None |
| 2009-10-24 |
TransMolecular announces final results from its Phase 2 clinical study of 131I-TM601 |
None |
| 2009-10-24 |
Media examines U.S., Mexico H1N1 vaccine campaigns, health effects of handwashing in Bolivia |
None |
| 2009-10-23 |
Nutri5, an effective natural product for the relief of menopausal symptoms |
3.7 |
| 2009-10-23 |
EFPIA launches a pilot project against counterfeit prescription medicines in Europe |
None |
| 2009-10-23 |
Analysis of the U.S. pharmaceutical industry by Aruvian Research |
1 |
| 2009-10-23 |
Vaccine Vial Monitors to monitor potential heat damage of H1N1 vaccines donated to WHO |
None |
| 2009-10-23 |
Shire announces new pharmacokinetic data of ADHD medication |
None |
| 2009-10-23 |
Key trends and events in the biopharma industry during the second quarter of 2009 |
None |
| 2009-10-23 |
Report on the world outlook for drug discovery technologies |
None |
| 2009-10-23 |
Boehringer Ingelheim receives European CHMP positive opinion for MICARDIS |
None |
| 2009-10-23 |
Archexin has potential to target and treat multiple life-threatening cancers, finds new study |
None |
| 2009-10-23 |
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets |
None |
| 2009-10-23 |
Report on the Russian pharmaceutical market |
None |
| 2009-10-23 |
Decision Resources predicts TNF-alpha inhibitors to dominate rheumatoid arthritis treatment |
None |
| 2009-10-23 |
Sinovac Biotech to distribute PANFLU.1 vaccine in Mexico |
None |
| 2009-10-23 |
New market research report on Ukraine's pharmaceuticals and healthcare industry |
None |
| 2009-10-23 |
Antidepressant prescriptions are on the rise |
None |
| 2009-10-23 |
Study: General anesthesia can cause brain injury in immature rats |
None |
| 2009-10-23 |
Report on worldwide markets for Botulinum Toxin |
None |
| 2009-10-23 |
Study reveals benefits of recombinant human C1 inhibitor in treating ischemic brain injury |
None |
| 2009-10-23 |
Relationship between cannabis and schizophrenia is controversial |
None |
| 2009-10-23 |
Key drivers in New Zealand's pharmaceutical market |
4 |
| 2009-10-23 |
MedImmune announces interim data from its live attenuated influenza vaccine studies |
None |
| 2009-10-23 |
Pfizer-Wyeth merger analyzed |
None |
| 2009-10-23 |
AEOL 10150 increases regeneration of GI stem cells: NIAID study results |
None |
| 2009-10-23 |
Combination treatement for IVF patients may eliminate vaginal bleeding |
None |
| 2009-10-23 |
In vitro activity results of Cem-101 against gram-positive organisms to be presented |
None |
| 2009-10-23 |
Canadian Cardiovascular Society to honor University of Alberta medical researcher |
None |
| 2009-10-23 |
Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide |
None |
| 2009-10-23 |
CellAura to provide pharmacologically validated reagents for Cisbio Bioassays' cellular studies |
None |
| 2009-10-23 |
Theravance earns milestone payment for bactericidal, injectable lipoglycopeptide antibiotic |
None |
| 2009-10-23 |
Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts |
None |
| 2009-10-23 |
XenaCare Holdings to advertise OTC pain reliever in NASCAR’s annual publication |
None |
| 2009-10-23 |
Majority of allergy patients can be vaccinated against swine flu after evaluation by an allergist |
None |
| 2009-10-23 |
Affymax to make multiple presentations on preclinical and clinical data of Hematide |
5 |
| 2009-10-23 |
45% of American adults not inclined to get vaccinated against seasonal flu |
None |
| 2009-10-22 |
AFP examines recent HIV vaccine findings |
None |
| 2009-10-22 |
LIVALO statin effective than simvastatin in reducing lipid levels |
2 |
| 2009-10-22 |
FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay |
None |
| 2009-10-22 |
Antiviral prescriptions at retail pharmacies increase by 36% in one week |
None |
| 2009-10-22 |
Report on Brigham updates in internal medicine and its specialties |
None |
| 2009-10-22 |
Amorfix Life Sciences signs sale and distribution agreement with Cedarlane Laboratories |
None |
| 2009-10-22 |
Current and future trends in the European HIV/AIDS therapeutic market |
None |
| 2009-10-22 |
2009 fourth-quarter update on Thailand's pharmaceuticals and healthcare industry |
None |
| 2009-10-22 |
Analysis of the Chinese pharmaceutical chain industry |
None |
| 2009-10-22 |
Faster insulin absorption for varying insulin doses and PH20 concentrations demonstrated |
None |
| 2009-10-22 |
Report on opportunities in the global H1N1 2009 influenza vaccine market |
None |
| 2009-10-22 |
PAREXEL to present key trends in late phase development and Comparative Effectiveness Research |
None |
| 2009-10-22 |
FDA extends Acorda Therapeutics' Fampridine-SR PDUFA goal date |
3 |
| 2009-10-22 |
Impact of global recession on the biopharma industry |
None |
| 2009-10-22 |
More infants are being immunized but funding gap leaves millions of children still at risk |
None |
| 2009-10-22 |
“Sid the Science Kid” show to explain the science behind flu vaccinations |
None |
| 2009-10-22 |
Advisory Committee on Immunization Practices supports the permissive use of GARDASIL |
None |
| 2009-10-22 |
Drug expert to discuss recent policy shift in medical marijuana at 2009 Symposium |
None |
| 2009-10-22 |
Study explores aldosterone antagonist usage among US patients hospitalised with heart failure |
None |
| 2009-10-22 |
Complex issue of CER in biopharmaceutical development explored |
None |
| 2009-10-22 |
Update from Karo Bio for the period January-September |
None |
| 2009-10-22 |
Report on Kazakhstan pharmaceuticals and healthcare industry from Research and Markets |
None |
| 2009-10-22 |
Comprehensive report on drug delivery partnering agreements in pharma and biotech industries |
None |
| 2009-10-22 |
Taiwan pharmaceuticals and healthcare report from Research and Markets |
None |
| 2009-10-22 |
2009 fourth-quarter report on Romania's pharmaceuticals and healthcare industry |
None |
| 2009-10-22 |
ISTA Pharmaceuticals' presentations on Phase 3 clinical results of Bepreve |
None |
| 2009-10-22 |
Cephalon announces receipt of a Paragraph IV Certification Notice Letter regarding ANDA |
None |
| 2009-10-22 |
Report on the United Arab Emirates' pharmaceuticals and healthcare industry |
None |
| 2009-10-22 |
Alacer launches new Emergen-C, a vitamin drink to boost immune systems |
None |
| 2009-10-22 |
New study on the demand for prostate cancer treatment drugs in China |
None |
| 2009-10-22 |
Study results of PTH1-34 oral parathyroid hormone presented |
5 |
| 2009-10-22 |
Study compares effects of clin-BPO 2.5% and clin-BPO 5% on epidermal functions |
None |
| 2009-10-22 |
GlaxoSmithKline's CERVARIX recommended by CDC for protection against cervical cancer |
None |
| 2009-10-22 |
Media outlets examine how AIDS vaccine trial results will shape future studies |
None |
| 2009-10-22 |
EU policies threaten developing countries drug supplies, report says |
None |
| 2009-10-22 |
Bioidentical Hormones for breast cancer prevention |
None |
| 2009-10-22 |
AIDS vaccine not as effective as first thought, scientists say |
None |
| 2009-10-22 |
Laureate Pharma signs development and manufacturing agreement to develop fusion protein products |
None |
| 2009-10-22 |
106m infants worldwide received vaccines last year, coverage gaps remain, report says |
None |
| 2009-10-21 |
EMEA informs Antigenics on a negative opinion for Oncophage MAA |
2 |
| 2009-10-21 |
Lux Biosciences to present on LX211 at 2009 AAO annual conference |
None |
| 2009-10-21 |
Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities |
None |
| 2009-10-21 |
Novavax, Xcellerex enter into collaboration to accelerate the development of Novavax's 2009 H1N1 vaccine |
None |
| 2009-10-21 |
FDA grants Fast Track designation for MacuSight's Perceiva |
None |
| 2009-10-21 |
Shire to file a Biologics License Application for REPLAGAL with the FDA |
None |
| 2009-10-21 |
King Pharmaceuticals receives FDA complete response letter for CorVue NDA |
None |
| 2009-10-21 |
Report on the health and wellness nutritional market in Denmark |
None |
| 2009-10-21 |
Purdue Pharma supports government prescription drug monitoring programs, grants NASCSA $200,000 |
None |
| 2009-10-21 |
Report on demand in the Chinese markets for breast cancer treatment drugs |
None |
| 2009-10-21 |
Report on Chinese market for autoimmune drugs |
None |
| 2009-10-21 |
Study of aldosterone antagonist usage among patients hospitalised with heart failure published |
None |
| 2009-10-21 |
Interim report from Medivir |
None |
| 2009-10-21 |
Report on the Chinese market for lung cancer treatment drugs |
None |
| 2009-10-21 |
Oxygen Biotherapeutics announces its expanded product development plan |
None |
| 2009-10-21 |
APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection |
None |
| 2009-10-21 |
Palmerolide A: Real hope for cancer treatment |
5 |
| 2009-10-21 |
Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles |
None |
| 2009-10-21 |
Comprehensive analysis of statin drug market |
2 |
| 2009-10-21 |
D2 Pharma Consulting develops "REMS Challenges and Real World Solutions" White Paper |
None |
| 2009-10-21 |
New market research report on China's drug development |
None |
| 2009-10-21 |
Drug abuse expert Dr. Drew Pinsky and the Five Moms join in fight against OTC cough medicine abuse |
4 |
| 2009-10-21 |
NIH grant for Lpath to advance clinical development of its antibody therapeutics |
None |
| 2009-10-21 |
No significant differences in pregnancy outcomes with different progesterone formulations |
None |
| 2009-10-21 |
Study on China's demand for incretion drugs |
None |
| 2009-10-21 |
Research shows exon-skipping drug may prove effective for treating Duchenne muscular dystrophy |
5 |
| 2009-10-21 |
Wellstat Therapeutics and Sanofi-Aventis to develop, manufacture and commercialize PN2034 |
None |
| 2009-10-21 |
Logical Therapeutics to present its clinical study results on LT-NS001 |
None |
| 2009-10-21 |
Report on China's biopharmaceuticals market |
None |
| 2009-10-21 |
CHA urges California Nurses Association to promote vaccinations to all health care workers |
None |
| 2009-10-21 |
Novo Nordisk's Levemir not associated with increase in the incidence of cancer |
None |
| 2009-10-21 |
Osteologix to continue clinical development of NB S101 osteoporosis drug |
None |
| 2009-10-21 |
Simcere and OSI Pharmaceuticals to market KDR/Kit inhibitor OSI-930 in China |
None |
| 2009-10-21 |
Inovio Biomedical highlights its advances in SynCon DNA vaccines |
None |
| 2009-10-20 |
As HIV vaccine conference opens, experts appeal for sustained commitment to global fight against disease |
None |
| 2009-10-20 |
ImPACKD calls for raising awareness about the risks of calcium overuse in CKD patients |
3 |
| 2009-10-20 |
Merck Frosst Canada announces the use of ISENTRESS for treating HIV-1 infected adults |
None |
| 2009-10-20 |
Boehringer Ingelheim continues providing non assert declarations to manufacture HIV/AIDS medicines |
None |
| 2009-10-20 |
TechnoVax receives NIH grant to further the development of its VLP-based, vaccine program |
None |
| 2009-10-20 |
Meeting to discuss latest information on anti-aging medicine and euthanasia |
None |
| 2009-10-20 |
GlaxoSmithKline to allow Apotex continue manufacturing their drug in Rwanda |
None |
| 2009-10-20 |
USP offers redesigned pharmaceutical standards format to improve key documentation process |
None |
| 2009-10-20 |
PCV vaccines can save the lives of millions of children |
None |
| 2009-10-20 |
AHF reiterates its disappointment over the presentation of Thai HIV vaccine study data |
None |
| 2009-10-20 |
Pharmacy services still in demand despite recession |
None |
| 2009-10-20 |
Competitive intelligence report on Chile's pharmaceuticals and healthcare industry |
None |
| 2009-10-20 |
Two high blood pressure medicines effective in treating stable ischemic heart disease |
None |
| 2009-10-20 |
Novavax, Avimex and GE Healthcare initiate clinical study of H1N1 VLP influenza vaccine |
None |
| 2009-10-20 |
ImmunoCellular Therapeutics files a provisional patent application |
None |
| 2009-10-20 |
Medical Marijuana offers "Turnkey Collective Solution" for collectives to conform to state laws |
None |
| 2009-10-20 |
Web site marketing fraudulent H1N1 flu supplements warned by the FDA and the FTC |
None |
| 2009-10-20 |
Trial collaborators present results from Prime-Boost HIV Vaccine Clinical Trial |
None |
| 2009-10-20 |
Alabama Supreme Court rules in favor of Novartis Pharmaceuticals |
5 |
| 2009-10-20 |
Shire Canada supports initiative for further access to antiretroviral medicine for Rwanda |
None |
| 2009-10-20 |
Potential hazards of H1N1 vaccine and seasonal flu shot not disclosed, say protesters |
5 |
| 2009-10-20 |
Cangene to acquire U.S. commercialization rights for HepaGam B |
None |
| 2009-10-20 |
Growth opportunities in the Middle Eastern pharmaceutical market |
None |
| 2009-10-20 |
Report on the evolving trends in biopharmaceutical licensing |
None |
| 2009-10-20 |
Fluarix seasonal influenza vaccine approved by the FDA |
None |
| 2009-10-20 |
GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic |
None |
| 2009-10-20 |
Updated report on Singapore's pharmaceuticals and healthcare industry |
None |
| 2009-10-20 |
Q4 2009 updated report of the Japanese pharmaceuticals and healthcare industry |
None |
| 2009-10-20 |
AstraZeneca and POZEN announce the pivotal data from two POZEN clinical trials |
None |
| 2009-10-20 |
Menarini granted exclusive European licence rights to Ipsen's Adenuric |
4 |
| 2009-10-20 |
Data on ULORIC treatment for gout flares presented at the 73rd American College of Rheumatology meeting |
None |
| 2009-10-20 |
Hydra Biosciences and Cubist Pharmaceuticals join to develop novel ion channel drugs |
None |
| 2009-10-20 |
Health Canada issues Notice of Non-Compliance to Winston Laboratories for CIVANEX |
None |
| 2009-10-20 |
Opinions: HIV vaccine; HIV resources help promote global disease control; U.S. fight against world hunger |
None |
| 2009-10-20 |
Amylin Pharmaceuticals to present new data from its obesity program at Obesity 2009 |
5 |
| 2009-10-20 |
Boehringer Ingelheim's TWYNSTA approved by FDA for the treatment of hypertension |
None |
| 2009-10-20 |
FDA approves new oral medication for renal cell carcinoma |
None |
| 2009-10-19 |
WHO recommends antivirals for patients with symptoms of both H1N1, pneumonia |
None |
| 2009-10-19 |
URL Pharma's Colcrys approved by FDA for prevention of gout flares |
None |
| 2009-10-19 |
Study on the economic impact of antibiotic overuse and antibiotic-resistant infections |
5 |
| 2009-10-19 |
FDA approves Boehringer Ingelheim's MICARDIS for the reduction of risk of heart attack |
None |
| 2009-10-19 |
FDA approves GlaxoSmithKline Biologicals' Cervarix for prevention of cervical cancer |
None |
| 2009-10-19 |
Hatch-Waxman patent infringement litigation concerning Duac Gel dismissed |
None |
| 2009-10-19 |
Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg |
5 |
| 2009-10-19 |
Update from Endo Pharmaceuticals regarding its New Drug Application for FORTESTA |
None |
| 2009-10-19 |
Amgen receives Complete Response Letter for the Biologic License Applications for Prolia from FDA |
None |
| 2009-10-19 |
Vaccinations and preventative hygiene routines can help protect families from H1N1 |
None |
| 2009-10-19 |
FDA approves Quotient Biodiagnostics' BLA for transfusion diagnostic monoclonal antibodies |
None |
| 2009-10-19 |
Report on the Malaysian pharmaceuticals and healthcare industry |
None |
| 2009-10-19 |
Viriom picks ChemDiv's Russian subsidiary for development of innovative HIV compounds |
None |
| 2009-10-19 |
Talecris Biotherapeutics' PROLASTIN-C receives FDA approval |
2.7 |
| 2009-10-19 |
AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH |
4 |
| 2009-10-19 |
Human Genome Sciences completes Phase 3 development program, earns $75 million from Novartis |
None |
| 2009-10-19 |
IAVI and Ragon Institute sign MOU to devise new vaccine strategies for AIDS |
None |
| 2009-10-19 |
Lubricin injections can reduce cartilage degeneration |
None |
| 2009-10-19 |
Preclinical data of carfilzomib and PR-957 inhibitors to be presented at 2009 ACR/ARHP meeting |
None |
| 2009-10-19 |
Majority of girls and young women well aware of HPV vaccine's benefits and limitations |
None |
| 2009-10-19 |
NCCN Clinical Practice Guidelines in Oncology updated to include pralatrexate drug |
None |
| 2009-10-19 |
Parents are concerned about the overuse of prescription medications with their children: Survey |
None |
| 2009-10-19 |
CONFIRMS trial demonstrates efficacy of ULORIC for treating hyperuricemia in patients with gout |
None |
| 2009-10-19 |
Research study on cowpox virus |
None |
| 2009-10-19 |
Rituxan's sBLA receives a Complete Response from the FDA |
None |
| 2009-10-19 |
FDA approves continuation of the fourth 6-month open label extension of PRX-03140 |
None |
| 2009-10-19 |
Antibiotic resistance to be undesirable consequence of antibiotic abuse is inaccurate, reveals report |
5 |
| 2009-10-19 |
Government closely monitors swine flu vaccine |
None |
| 2009-10-19 |
Novel HIV drug to be studied in cell cultures and patients |
None |
| 2009-10-19 |
Biogen Idec and Biovitrum to conduct rFIXFc clinical trial in hemophilia B patients |
None |
| 2009-10-19 |
Exposure to online media increases treatment's awareness and favorability: Study |
None |
| 2009-10-19 |
Aurora Visiting Nurse Association to suspend its seasonal flu vaccination clinics |
None |
| 2009-10-19 |
PHARMACIA & UPJOHN COMPANY to pay the largest criminal fine ever imposed in the U.S. |
None |
| 2009-10-19 |
Ruthenium and Osmium compounds show high levels of activity against ovarian cancer |
None |
| 2009-10-19 |
FDA grants marketing approval for Elitek |
None |
| 2009-10-19 |
Warning letter to Procter & Gamble posted in error |
None |
| 2009-10-19 |
FDA approves Gardasil vaccine usage in boys and men for preventing genital warts |
5 |
| 2009-10-19 |
Pfizer acquires Wyeth; begins joint operations |
None |
| 2009-10-19 |
Rituxan drug effective for treating ANCA-associated vasculitis |
None |
| 2009-10-19 |
Recently approved Gleevec drug for cancer treatment |
None |
| 2009-10-19 |
Findings may yield new treatments for COPD |
None |
| 2009-10-19 |
CK Life Sciences acquires additional voting shares of WEX Pharmaceuticals |
None |
| 2009-10-19 |
GlaxoSmithKline receives FDA approval for cervical cancer vaccine |
None |
| 2009-10-19 |
Multi-million dollar cooperative agreement for SMA drug development program |
None |
| 2009-10-19 |
FDA approves 100th antiretroviral for PEPFAR |
None |
| 2009-10-15 |
Access Pharmaceuticals' update on its European commercial launch of Mugard |
None |
| 2009-10-15 |
FDA launches web page with information on how to dispose of certain drugs |
None |
| 2009-10-15 |
Mylan Pharmaceuticals receives approval for Topiramate Capsules |
None |
| 2009-10-15 |
MDS secures international cooperation to help Canadian teenager with malignant blood disorder |
None |
| 2009-10-15 |
AcelRx Pharmaceuticals’ programs to feature at upcoming annual meeting |
None |
| 2009-10-15 |
European authorities approve Medivir’s marketing authorisation application in 14 European countries |
None |
| 2009-10-15 |
Northern Light partners with EBSCO Publishing to provide bio-pharma and health sciences news |
5 |
| 2009-10-15 |
Pharma IQ reports on the 7th Annual Cold Chain Distribution for Pharmaceuticals conference |
None |
| 2009-10-15 |
BNA Books publishes the 2009 Cumulative Supplement to Pharmaceutical Patent Law |
None |
| 2009-10-15 |
Negative symptoms represent an attractive target for drug development |
None |
| 2009-10-15 |
Patients on statin drugs may have lower AAA surgery costs |
None |
| 2009-10-15 |
Fibromyalgia market to more than double by 2018 |
None |
| 2009-10-15 |
PIKAMAB obtains U.S. patent rights to develop theragnostic product |
None |
| 2009-10-15 |
Survey reports patients' concern about the safety and access to flu vaccines |
None |
| 2009-10-15 |
BioTech Medics' SHBAN Hand Sanitizer Solution kills H1N1 Influenza A virus |
5 |
| 2009-10-15 |
NexMed completes its post hoc analysis of NM100060 |
None |
| 2009-10-15 |
Cobroxin OTC pain reliever is now available online |
4.7 |
| 2009-10-15 |
Co-promotion agreement to promote Prosed DS to urologists and retail pharmacists |
None |
| 2009-10-15 |
Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction |
2 |
| 2009-10-15 |
Paratek Pharmaceuticals, Novartis ink worldwide licensing agreement for PTK 0796 |
None |
| 2009-10-15 |
Mylan Pharmaceuticals and Matrix Laboratories enter into license agreement with Pfizer |
None |
| 2009-10-15 |
Decision Resources forecasts biosimilar insulins and insulin analogues to erode $6.1 billion in brand sales |
5 |
| 2009-10-15 |
Required flu vaccines for New York health workers draws criticism |
None |
| 2009-10-15 |
Critical Pharmaceuticals to develop hGH nasal spray |
None |
| 2009-10-15 |
Eden Biodesign to manufacture Biotecnol's Cardiotrophin-1 |
None |
| 2009-10-15 |
Interim data from Sanofi Pasteur's Influenza A 2009 Monovalent Vaccine clinical trials in infants and children |
None |
| 2009-10-15 |
Genetic diversity thwarts the usefulness of malaria vaccine |
None |
| 2009-10-15 |
Fero Industries to acquire Pyro Pharmaceuticals |
None |
| 2009-10-15 |
Less expensive anti-rejection drug as effective as more expensive drug, says study |
None |
| 2009-10-15 |
Postive vote from FDA Advisory Committee for Fampridine-SR 10 |
None |
| 2009-10-15 |
Atlantic examines flu vaccine, antiviral skepticism |
None |
| 2009-10-14 |
New market research report on global generic industry landscape |
None |
| 2009-10-14 |
Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement |
None |
| 2009-10-14 |
Experts to discuss the safety of H1N1 flu vaccine |
None |
| 2009-10-14 |
Presentation on L-DOS47 drug formulation and development at Pharmaceutical Industry Conference |
None |
| 2009-10-14 |
Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103 |
None |
| 2009-10-14 |
Brain researcher finds how the epilepsy and pain drug works |
None |
| 2009-10-14 |
Sinovac Biotech announces receipt of Panflu vaccine distribution approval in Hong Kong |
None |
| 2009-10-14 |
2010 TIPPS certification for Prime Therapeutics |
None |
| 2009-10-14 |
Connexin Software announces updated EMR software version to support H1N1 vaccine administration |
None |
| 2009-10-14 |
Harvard researchers unite in fight against antibiotic resistance |
None |
| 2009-10-14 |
Cequent Pharmaceuticals to provide details of its clinical program at BIOCOM conference |
None |
| 2009-10-14 |
FDA recommends approval for UI Pharmaceuticals to manufacture an aseptically filled sterile drug product |
None |
| 2009-10-14 |
Inovio Biomedical's proprietary DNA vaccine development platform introduced |
5 |
| 2009-10-14 |
T.S. Wiley to lecture on the latest advances in anti-aging medicine |
None |
| 2009-10-14 |
Champions Biotechnology receives U.S. patent for its tubulin inhibitors |
None |
| 2009-10-14 |
NIH awards UNC researcher $507,000 for rotavirus vaccine study |
None |
| 2009-10-14 |
Older generation antibiotic for treating colon cancer |
5 |
| 2009-10-14 |
National Vaccine Information Center to launch a research fundraising campaign |
5 |
| 2009-10-14 |
Researchers test Orizon Research's ALKA-V6 silicon-based compound |
None |
| 2009-10-14 |
NIH awards Novavax a SBIR grant for respiratory syncytial virus vaccine research |
None |
| 2009-10-14 |
ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers |
None |
| 2009-10-14 |
Shire settles pending ADDERALL XR litigation with Sandoz |
None |
| 2009-10-14 |
Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG |
None |
| 2009-10-14 |
Researchers to investigate an existing drug for speedy recovery of stroke patients |
None |
| 2009-10-14 |
Decision Resources: Rheumatoid arthritis drug market in India to grow up to $672 million in 2013 |
None |
| 2009-10-14 |
Rapid rollout of H1N1 vaccines is effective in reducing infection rates according to simulation model |
None |
| 2009-10-14 |
Epeius Biotechnologies announces clinical study results of tumor-targeted genetic medicine |
None |
| 2009-10-14 |
Unapproved codeine sulfate tablets: FDA warns four companies to stop marketing |
None |
| 2009-10-14 |
Bladder cancer patients benefit from anticancer drug that is used to treat lung and colon malignancies: Study |
None |
| 2009-10-14 |
Report highlighting the structure, market size and growth rate of the Indian pharmaceutical industry |
5 |
| 2009-10-14 |
African leaders, Chirac unite to fight fake drug manufacturing, distribution |
None |
| 2009-10-13 |
Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain |
None |
| 2009-10-13 |
Sequella receives Phase 1 SBIR grant for developing SQ641 |
None |
| 2009-10-13 |
Pharmaceuticals to provide safe needle collection and disposal programs for patients |
None |
| 2009-10-13 |
Onyx Pharmaceuticals signs definitive agreement to acquire Proteolix |
None |
| 2009-10-13 |
Merck Frosst Canada's JANUMET receives Notice of Compliance in Canada |
None |
| 2009-10-13 |
Psoriasis patients taking immunosuppressive drugs at increased risk of H1N1 flu viruses |
None |
| 2009-10-13 |
Simple wound dressings versus antimicrobial dressings |
5 |
| 2009-10-13 |
Frost & Sullivan presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry |
None |
| 2009-10-13 |
Impact of competitive dynamics in the U.S. pharmaceutical market |
None |
| 2009-10-13 |
SAFC Pharma expands contract manufacturing services |
None |
| 2009-10-13 |
Contaminated pre-filled heparin and saline syringes cause bloodstream infections |
None |
| 2009-10-13 |
Health care workers raise troubling concern about H1N1 and seasonal flu vaccines |
None |
| 2009-10-13 |
Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl |
None |
| 2009-10-13 |
VitalProteinRx nutritional supplement for chronic kidney disease affected patients |
None |
| 2009-10-13 |
Spectrum Pharmaceuticals receives Complete Response letter from the FDA for FUSILEV |
None |
| 2009-10-13 |
Vanda Pharmaceuticals' Fanapt to be commercialized in the U.S. and Canada by Novartis Pharma |
None |
| 2009-10-13 |
New guidelines for treating amyotropic lateral sclerosis |
None |
| 2009-10-13 |
Inflammation markers not involved with the chemopreventative effect of aspirin on colorectal adenomas |
None |
| 2009-10-13 |
Cox's initiative to safeguard the community at-large |
None |
| 2009-10-13 |
Fully-insured members of Guardian to receive 100% coverage of the administrative cost of H1N1 vaccine |
None |
| 2009-10-12 |
Contribution of pharmacovigilance to pharmaceutical development and marketing |
None |
| 2009-10-12 |
Educational video on seasonal and H1N1 vaccines development |
None |
| 2009-10-12 |
Low-, middle-income countries could receive donated H1N1 vaccine shipments by November, WHO says |
None |
| 2009-10-12 |
Some scientists question results of recent HIV vaccine clinical trial |
None |
| 2009-10-12 |
Even with early shortages, public is conflicted about getting the swine flu vaccine |
None |
| 2009-10-12 |
Research and Markets offers new report on UK pharmaceutical sector |
None |
| 2009-10-12 |
B. Braun Medical announces agreement with HealthTrust to provide pain management products |
None |
| 2009-10-12 |
QRxPharma signs contractual agreement with Patheon |
None |
| 2009-10-12 |
Z-Medica launches QuikClot Trauma Pad |
None |
| 2009-10-12 |
FDA grants marketing approval for CSL Behring's Berinert C1-Esterase Inhibitor |
None |
| 2009-10-12 |
Communications technology for students and employees to manage their healthcare relationships |
None |
| 2009-10-12 |
ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza |
None |
| 2009-10-12 |
Frost & Sullivan: EU contract research organization market estimated to reach $13.52 billion in 2015 |
None |
| 2009-10-12 |
Santarus and Norgine enter into a licensing agreement for ZEGERID products |
None |
| 2009-10-12 |
Report on the size of the cough, cold and allergy products market in China |
None |
| 2009-10-12 |
Report on newer approaches to cancer treatment |
None |
| 2009-10-12 |
New market research report on China vaccine industry |
None |
| 2009-10-12 |
Heptares Therapeutics to apply its StaR technology to generate novel drug leads against GPCR target |
None |
| 2009-10-12 |
Pieris reports its progress in the development of PRS-050 |
None |
| 2009-10-12 |
Report on the generic drug market in Canada |
None |
| 2009-10-12 |
PPA bus tour to raise awareness of patient assistance programs |
None |
| 2009-10-12 |
FDA approves Berinert for the treatment of hereditary angioedema |
None |
| 2009-10-12 |
Arch Pharmalabs collaborates with Orochem Technologies to manufacture an API in India |
None |
| 2009-10-12 |
Presentations on efficacy of interferon to combat influenza |
5 |
| 2009-10-12 |
Wal-Mart Stores to offer Tamiflu oral suspension in liquid form for children and elderly |
5 |
| 2009-10-09 |
Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy |
None |
| 2009-10-09 |
State governments start swine flu vaccine campaign |
None |
| 2009-10-09 |
Report on the European and U.S. market for omega-3 |
2 |
| 2009-10-09 |
CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis |
5 |
| 2009-10-09 |
Impact of wellness programs on the pharmaceutical, diagnostic and device product market |
None |
| 2009-10-09 |
St. Petersburg City Council partners with American Lung Association for "Faces of Influenza" campaign |
None |
| 2009-10-09 |
Report on evolving pharmaceutical sales landscape |
None |
| 2009-10-09 |
FDA Advisory Committee approves use of Selzentry tablets in combination with HIV therapy |
None |
| 2009-10-09 |
The Quebec Biopharmaceutical Strategy lauded by Sanofi-aventis |
None |
| 2009-10-09 |
CytoDyn to conduct a study on Cytolin at Massachusetts General Hospital |
1 |
| 2009-10-09 |
NIAID awards $60M for research contracts to discover new adjuvants |
None |
| 2009-10-09 |
New soy germ-based ingredient improves menopausal symptoms |
4 |
| 2009-10-09 |
AHF criticizes Pfizer for its current pricing of Selzentry AIDS drug |
None |
| 2009-10-09 |
Research study on HPV vaccination efficacy for boys and girls |
None |
| 2009-10-09 |
Ipsen signs exclusive marketing agreement to produce and distribute Braintree's BLI-800 for colonic cleansing |
None |
| 2009-10-09 |
Clemson bioengineer designing new ways to target drugs |
None |
| 2009-10-09 |
CardioPharma to submit an NDA for CardiaPill |
None |
| 2009-10-09 |
Research rules out link between MMR vaccines and autism |
2.5 |
| 2009-10-09 |
Hospira and Celltrion agree to develop and market eight biogeneric products |
None |
| 2009-10-09 |
NHLBI to hold Symposium to review latest findings in Cardiovascular Regenerative Medicine |
None |
| 2009-10-09 |
U.S. should provide more leadership in finding TB vaccine, opinion piece says |
None |
| 2009-10-08 |
Angiochem to announce clinical study results of ANG1005 drug |
None |
| 2009-10-08 |
Emisphere Technologies announces commercial launch of oral Eligen B12 |
None |
| 2009-10-08 |
Epitope spreading can get triggered by live, attenuated Listeria vaccine |
None |
| 2009-10-08 |
BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain |
None |
| 2009-10-08 |
Biocodex secures consumer distribution with CVS stores nationwide for its Florastor |
None |
| 2009-10-08 |
Grunenthal to distribute Labopharm's tramadol-acetaminophen formulation in EU market |
None |
| 2009-10-08 |
CombinatoRx' Prednisolone/Dipyridamole Combination abstract to be presented at the ACR 2009 |
None |
| 2009-10-08 |
New cancer drugs boost drug spending |
None |
| 2009-10-08 |
Report on drug utilization in Chinese hospitals |
None |
| 2009-10-08 |
New guide on direct to consumer communication in the pharmaceutical industry |
None |
| 2009-10-08 |
Ipsen and Spirogen sign new licensing agreement for development of SJG-136 anticancer agent |
None |
| 2009-10-08 |
Mimetogen Pharmaceuticals completes its equity financing |
None |
| 2009-10-08 |
Birth control pills may have an impact on choice of partners |
None |
| 2009-10-08 |
Sinobiopharma receives certificate for using Gabexate Mesylate as pharmaceutical raw material |
5 |
| 2009-10-08 |
Labopharm's trazodone API supplier Angelini resolves manufacturing facility deficiencies |
None |
| 2009-10-08 |
Researchers reveal that H2 Blocker drugs pose no significant risks for the fetus |
None |
| 2009-10-08 |
Ariad Healthcare chosen to be lead marketing agency for Multibionta Probiotic Multivitamin |
4 |
| 2009-10-08 |
Rite Aid pharmacists provide regular seasonal flu shots to help prevent flu |
None |
| 2009-10-08 |
Antidotes effective for treating acute liver failure patients in early stages of disease |
None |
| 2009-10-08 |
Triple therapy may benefit patients with chronic obstructive pulmonary disease |
None |
| 2009-10-08 |
HTDS' Hepatitis A vaccine receives GMP Certificate from the Russian FDA |
None |
| 2009-10-08 |
Global pharmaceutical market to grow by 4 - 6 percent: IMS Health |
None |
| 2009-10-08 |
Napo Pharmaceuticals hosts educational panel to address global health and environment |
None |
| 2009-10-08 |
APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection |
None |
| 2009-10-07 |
Biostar Pharmaceuticals' new drug application granted clearance for clinical trials |
None |
| 2009-10-07 |
FDA approves Daiichi Sankyo's sNDA for Welchol |
None |
| 2009-10-07 |
Government handout of samples of potassium iodide helps to boost sales for Nukepills.com |
5 |
| 2009-10-07 |
Nutra Pharma to launch prescription analgesic for severe chronic pain treatment |
None |
| 2009-10-07 |
Shire publishes efficacy study results of FOSRENOL and Renagel |
None |
| 2009-10-07 |
Impax Laboratories settles FLOMAX litigation, to launch generic tamsulosin hydrochloride product |
None |
| 2009-10-07 |
Baxter receives marketing authorization for CELVAPAN H1N1 pandemic influenza vaccine |
None |
| 2009-10-07 |
Promotional speaker programs on the latest drug developments help pharma companies attract physicians |
None |
| 2009-10-07 |
Market research report on the innovative drug R&D in China |
None |
| 2009-10-07 |
FDA reviews Fibrocell Science's BLA for azfibrocel-T |
5 |
| 2009-10-07 |
aTyr Pharma to discuss aminoacyl tRNA synthetases at the BioPartnering Europe Conference |
None |
| 2009-10-07 |
Deadline for pharmacies to meet Medicare’s DMEPOS accreditation requirements extended, Senate lauded |
None |
| 2009-10-07 |
Galapagos receives EUR 500,000 cash payment from GSK |
None |
| 2009-10-07 |
GlobeImmune to present an abstract of GI-5005 drug at AASLD's annual meeting |
None |
| 2009-10-07 |
Helix BioPharma's pre-IND meetings with the FDA for Topical Interferon Alpha-2b and L-DOS47 fruitful |
None |
| 2009-10-07 |
HHS and PEPFAR approve the 100th HIV/AIDS antiretroviral drug |
1 |
| 2009-10-07 |
FDA provides Genzyme a complete response letter for Clolar NDA |
None |
| 2009-10-07 |
FDA completes inspection of Catalent Pharma's manufacturing facility in Germany |
None |
| 2009-10-07 |
Daily doses of imatinib mesylate double survival rates in Ph+ ALL affected children |
None |
| 2009-10-07 |
Research on malarial drugs for travelers |
None |
| 2009-10-07 |
Opioid drugs may not be effective for osteoarthritis |
5 |
| 2009-10-07 |
Cochrane Systematic Review finds Abatacept effective against rheumatoid arthritis |
None |
| 2009-10-07 |
Combination of leukemia and breast cancer drugs inhibits cancer progression |
None |
| 2009-10-07 |
Pennsylvania to receive first doses of live attenuated pandemic H1N1 influenza vaccine |
5 |
| 2009-10-07 |
Get vaccinated against both H1N1 flu and the seasonal flu, advises Chief Nurse of the American Red Cross |
None |
| 2009-10-07 |
PSI-879 nominated as second development candidate for treating HCV infection |
None |
| 2009-10-07 |
African leaders gather to discuss ways to bolster continent's drug, diagnostic development |
None |
| 2009-10-07 |
Researchers make breakthrough in finding a vaccine against horse disease strangle |
None |
| 2009-10-06 |
iMedicor to market Access Pharmaceuticals' MuGard in North America |
None |
| 2009-10-06 |
The latest medication to treat schizophrenia "ABILIFY" launched in Canada |
3.2 |
| 2009-10-06 |
Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin |
None |
| 2009-10-06 |
The global outlook on Alternative Medicine - a new report |
None |
| 2009-10-06 |
Report on the major trends driving the biodefense market |
None |
| 2009-10-06 |
FDA Advisory Committee approves Peginterferon alfa-2b for treating metastatic melanoma |
None |
| 2009-10-06 |
Salix Pharmaceuticals granted rights to use Lupin's bioadhesive drug delivery technology |
None |
| 2009-10-06 |
Scientia Advisors announces the results of an in-depth study of the changing vaccine industry |
None |
| 2009-10-06 |
FDA accepts ProStrakan's Abstral NDA filing for review |
None |
| 2009-10-06 |
Vivaldi receives US patent for live attenuated influenza vaccines |
None |
| 2009-10-06 |
Government of Alberta reimburses first medication to improve vision and restore quality of life |
None |
| 2009-10-06 |
Report on emerging therapies in the global diabetes market |
None |
| 2009-10-06 |
DuraPrep solution effective against surgical-site infections |
5 |
| 2009-10-06 |
EP-100 membrane-disrupting peptide drug for cancer being tested at TCRS |
5 |
| 2009-10-06 |
Inviragen, SingVax merge their complementary vaccine pipelines |
None |
| 2009-10-06 |
Fresenius Medical Care to offer seasonal influenza and H1N1 flu vaccines |
None |
| 2009-10-06 |
Vaccine to treat cocaine dependence reduces use of the drug, according to study |
None |
| 2009-10-06 |
Sequella receives ARRA funds to manufacture SQ109 for treating tuberculosis |
None |
| 2009-10-06 |
Schering-Plough receives FDA recommendation approval for PEGINTRON |
4 |
| 2009-10-06 |
FDA's Oncologic Drugs Advisory Committee recommends approval of GlaxoSmithKline's VOTRIENT |
None |
| 2009-10-06 |
U.N. officials highlight need for vaccine assistance to poor countries |
None |
| 2009-10-06 |
Report on inhaled pharmaceutical therapy developers |
5 |
| 2009-10-06 |
FOLOTYN available for commercial sale in the United States |
None |
| 2009-10-05 |
AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection |
None |
| 2009-10-05 |
Bristol-Myers Squibb and AstraZeneca receive marketing authorisation for ONGLYZA in Europe |
None |
| 2009-10-05 |
LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction |
None |
| 2009-10-05 |
Phase 3 clinical study results of Ketotransdel topical cream to be presented |
None |
| 2009-10-05 |
Baxter launches HYLENEX recombinant for pediatric rehydration at the 2009 ACEP |
None |
| 2009-10-05 |
Preclinical study results of AVL-181 protease inhibitor presented |
5 |
| 2009-10-05 |
FDA grants Impax tentative approval of ANDA for FLOMAX generic version |
None |
| 2009-10-05 |
Research, development and commercialization of drug delivery technologies |
None |
| 2009-10-05 |
Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology |
None |
| 2009-10-05 |
Lupin grants Salix exclusive rights to its bioadhesive drug delivery technology for use with rifaximin |
None |
| 2009-10-05 |
Allergan files declaratory relief action to allow it to share relavant information on BOTOX |
None |
| 2009-10-05 |
World generics market report till 2024 from Reportlinker |
None |
| 2009-10-05 |
Second round of revised quality standards for blood thinner heparin released |
None |
| 2009-10-05 |
Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released |
None |
| 2009-10-05 |
Pharma and biotech companies to assess new FDA REMS guidance |
None |
| 2009-10-05 |
comScore study results of changes in search engine marketing in the pharmaceutical industry |
None |
| 2009-10-05 |
The Lewin Group issues recommendations to overcome barriers obstructing the lupus drug development |
None |
| 2009-10-05 |
Workshop to revise and update Pharmacy Benefit Management and Drug Therapy Management |
None |
| 2009-10-04 |
Researchers engineer antidotes for blood-thinner aptamers |
None |
| 2009-10-03 |
APP Pharmaceutical continues support of FDA's USP standards for unfractionated heparin |
None |
| 2009-10-03 |
Caraco closes Asset Purchase Agreement with Forest as part of ANDA patent litigation settlement |
None |
| 2009-10-03 |
HSPH's survey on H1N1 vaccines |
5 |
| 2009-10-03 |
Report on the worldwide market for anti-infectives |
None |
| 2009-10-03 |
Publix Pharmacies offers to compound Tamiflu into an oral suspension for no additional charge |
None |
| 2009-10-03 |
Misuse of aspirin might have caused high death rate during 1918-1919 influenza pandemic |
None |
| 2009-10-03 |
New study shows that NovoMix 30 is effective for type 2 diabetes patients who are to start on insulin |
3 |
| 2009-10-03 |
Bradycardia more likely in patients taking cholinesterase inhibitors |
None |
| 2009-10-03 |
TNF-alpha inhibitor drug class sales to increase up to $1.1 billion in 2018 |
None |
| 2009-10-03 |
Chinese government places second purchase order for Sinovac Biotech's H1N1 vaccine |
5 |
| 2009-10-03 |
Sagent announces launch of vinorelbine injection |
None |
| 2009-10-03 |
Vaccinate children with H1N1 flu vaccine to control swine flu: UAB |
None |
| 2009-10-03 |
New strategic research service for the oncology market launched by Health Strategies Group |
None |
| 2009-10-03 |
Clinical study data of Thymosin beta 4 presented |
None |
| 2009-10-03 |
90% of public support H1N1 vaccination for health care workers |
1 |
| 2009-10-03 |
BioDelivery Sciences International files NDS for BEMA Fentanyl |
None |
| 2009-10-03 |
EMEA grants positive opinion for Baxter's CELVAPAN H1N1 pandemic vaccine |
None |
| 2009-10-03 |
Americans are not getting correct drug information, says study |
None |
| 2009-10-03 |
First U.S. patients could receive H1N1 vaccine next week |
None |
| 2009-10-03 |
Update from BioCryst Pharmaceuticals regarding antiviral peramivir |
None |
| 2009-10-03 |
Nutra Pharma manufactures first commercial batch of Cobroxin |
5 |
| 2009-10-03 |
FDA grants Fast Track designation to Corthera's relaxin for treating acute heart failure |
None |
| 2009-10-03 |
CNN, TIME examine increasing antibiotic resistance |
5 |
| 2009-10-03 |
ALL initiative three-year clinical observational study results published |
None |
| 2009-10-02 |
New study underscores lack of appropriate government action to ensure safety of vaccines |
3 |
| 2009-10-02 |
Array BioPharma to present poster on ARRY-403 glucokinase activator |
2 |
| 2009-10-02 |
Molecular mechanisms of BN108 and timosaponin AIII described in a journal |
None |
| 2009-10-02 |
sNDA for Clonicel submitted to the FDA |
None |
| 2009-10-02 |
Clinical study results demonstrate the efficacy of AFRESA inhalation powder |
None |
| 2009-10-01 |
Change in Heparin manufacturing - expected to decrease the potency |
None |
| 2009-10-01 |
Actavis' clients launch generic Atorvastatin in Spain |
None |
| 2009-10-01 |
Mayo study reveals infliximab reduces the need for colectomy |
None |
| 2009-10-01 |
HRA Pharma launches its new generation emergency contraceptive in Europe |
None |
| 2009-10-01 |
GSK allowed access to DiscoveRx' PathHunter ß-Arrestin parental cell lines and reagents |
None |
| 2009-10-01 |
Advaxis announces Phase I trial results of its ADXS11-001 therapeutic cancer vaccine |
None |
| 2009-10-01 |
First prescription foam formulation of benzoyl peroxide available |
None |
| 2009-10-01 |
Health Canada approves VIBATIV for treating complicated skin and skin structure infections |
None |
| 2009-10-01 |
Addrenex submits a sNDA to the FDA for Clonicel |
None |
| 2009-10-01 |
Diamyd Medical signs agreement with Inclinix to conduct global Phase III program |
None |
| 2009-10-01 |
Scientific Advisory Board to provide guidance to support the development of FST-100 |
None |
| 2009-10-01 |
CVS Caremark to offer vouchers worth $3 million for free seasonal flu shots |
None |
| 2009-10-01 |
FDA releases first draft guidance on Risk Evaluation and Mitigation Strategies for select drugs |
None |
| 2009-10-01 |
Study aims to discover effective antibiotics to fight against hard-to-treat microbes |
None |
| 2009-10-01 |
Cutting Edge Information hopes to see ill patients have speedier access to potential cures |
None |
| 2009-10-01 |
Comprehensive analysis of the Chinese pharma sector |
None |
| 2009-10-01 |
USPTO allows BioMarin's claims covering the approved administration of sapropterin dihydrochloride with food |
None |
| 2009-10-01 |
Drug companies take immediate measures to deliver millions of H1N1 vaccines |
None |
| 2009-10-01 |
FDA completes inspection of Hovione's API plant in Loures, Portugal |
None |
| 2009-10-01 |
Researchers stress the importance of ensuring quality psychiatric treatment in general practice settings |
None |
| 2009-10-01 |
Medicaid members to receive cover for administration cost of the H1N1 vaccine from WellCare |
None |
| 2009-10-01 |
Report on the Oman pharmaceuticals and healthcare industry |
None |
| 2009-10-01 |
Bristol-Myers announces availability of ERBITUX for metastatic colorectal cancer treatment |
None |
| 2009-10-01 |
Swine flu vaccine distribution plan for Pennsylvania |
None |
| 2009-10-01 |
EMD Serono submits NDA for Cladribine Tablets in the U.S. |
None |
| 2009-10-01 |
Poll reveals that 43% of American adults undecided about getting the swine flu vaccine |
None |
| 2009-10-01 |
Update from BioCryst Pharmaceuticals regarding intravenous peramivir |
None |